Solenis Acquires Diversey for $4.6 Billion

Solenis, a specialty chemicals manufacturer for water-intensive industries, has completed its acquisition of Diversey, a hygiene and cleaning products provider, in an all-cash transaction valued at ~ $4.6 billion.

With this acquisition, Solenis now operates in over 130 countries with 71 manufacturing facilities and over 15,000 employees.

“We now have greatly enhanced capabilities to help our customers tackle critical sustainability challenges, reduce their environmental impact and help create a cleaner, safer world,” said John Panichella, CEO, Solenis.

Solenis has been owned by Platinum Equity since its acquisition in 2021. The majority shareholder of Diversey, Bain Capital, will now be a minority stakeholder in Solenis after the merger. 

Solenis and Diversey unite in $4.6 billion acquisition. © Solenis
Solenis and Diversey unite in $4.6 billion acquisition. © Solenis

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read